MedPath
NMPA Approval

Sulfadiazine Sodium Injection

国药准字H44022536

May 26, 2021

国药准字H44022536

Drug Information

磺胺嘧啶钠注射液

注射剂

2ml:0.4g

化学药品

May 26, 2021

Company Information

Applicant Company

广东省湛江市机场路16号

Manufacturing Company

广东省湛江市机场路16号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磺胺嘧啶钠注射液 - NMPA 批准文号 | MedPath